icddr,b
↗Dhaka, Bangladesh
icddr,b is a premier international health research institution based in Dhaka, Bangladesh. Originally established in 1960 as the SEATO Cholera Research Laboratory, it has evolved into a global leader in infectious disease research, nutrition, and maternal and child health. The centre is world-renowned for its role in the discovery and implementation of Oral Rehydration Therapy (ORT), which is estimated to have saved over 50 million lives globally.
The organization operates as an autonomous, nonprofit research centre, conducting a wide range of activities including laboratory-based research, large-scale clinical trials, and demographic surveillance. It maintains the world's longest-running health and demographic surveillance site in Matlab, Bangladesh. icddr,b collaborates with major global health entities such as the WHO, UNICEF, and the Bill & Melinda Gates Foundation to develop low-cost, evidence-based solutions for public health challenges in low- and middle-income countries.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease Research & Vaccine Evaluation
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$50M-$100M
Founded:1960
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:$77.3M (2023 Revenue)
Investors:USAID, Bill & Melinda Gates Foundation, Global Affairs Canada (GAC), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Swedish International Development Cooperation Agency (Sida), Foreign, Commonwealth & Development Office (FCDO), The Global Fund
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Vaccine Evaluation)
Modalities:Vaccines, Small molecule, Nutritional Interventions, Diagnostics
Active Trials:45
Trial Phases:Phase 1: 8 | Phase 2: 15 | Phase 3: 12 | Phase 4: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Dhaka Hospital, Matlab Health Research Centre, icddr,b Genome Centre
Key Partnerships:World Health Organization (WHO) - Vaccine evaluation and policy, UNICEF - Maternal and child health programs, Washington University in St. Louis - Microbiota research, University of Oxford - Nipah virus vaccine trials, Stanford University - Environmental health research
COMPETITION
Position:Leader
Competitors:PATH, KEMRI (Kenya Medical Research Institute), IVS (International Vaccine Institute), BRAC Health
LEADERSHIP
Key Executives:
Dr. Tahmeed Ahmed - Executive Director
Dr. Md. Mustafizur Rahman - Senior Director, Infectious Diseases Division
Dr. Md. Anisur Rahman - Senior Director, Maternal and Child Health Division
Scientific Founders:Dilip Mahalanabis, David R. Nalin, Richard A. Cash
Board Members:Nancy Y. Cheng (Chair), Dr. Suman Rijal (WHO Nominee), Dr. Francis Odhiambo (UNICEF Nominee), Andrea J. Lucard (Medicine for Malaria Venture)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with icddr,b. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.